European Journal of Pediatrics

, Volume 150, Issue 10, pp 730–731 | Cite as

Neonatal citrullinaemia with satisfactory mental development

  • P. Sanjurjo
  • J. Rodríguez-Soriano
  • A. Vallo
  • A. Arranz
  • V. Rubio
Metabolic Diseases


In an infant with neonatal citrullinaemia therapy was instituted on day 1 of life with a low-protein diet and oral supplements of arginine, α-keto-acids, essential amino acids and carnitine. The latter may have contributed to the excellent clinical outcome, as evidenced by normal growth and satisfactory psychomotor development at 3 years of age.

Key words

Urea cycle metabolism disorders Citrullinaemia Hyperammonaemia Carnitine 


  1. 1.
    Batshaw M, Brusilow SW (1980) Treatment of hyperammonemic coma caused by inborn errors of urea synthesis. J Pediatr 97:893–900PubMedGoogle Scholar
  2. 2.
    Buist NRM, Kennaway NG, Hepburn CA, Strandholm JJ, Ramberg DA (1974) Citrullinemia: investigation and treatment over a four-year period. J Pediatr 85:208–214PubMedGoogle Scholar
  3. 3.
    Costell M, Miguez MP, O'Connor JE, Grisolía S (1987) Effect of hyperammonemia on the levels of carnitine in mice. Neurology 37:804–808PubMedGoogle Scholar
  4. 4.
    Danks DM, Tippet P, Zetner G (1974) Severe neonatal citrullinemia. Arch Dis Child 49:579–581PubMedGoogle Scholar
  5. 5.
    Kleijer WJ, Thoomes R, Galjaard H, Wendel U, Fowler B (1984) First-trimester (chorion biopsy) diagnosis of citrullinemia and methylmalonicacidurie. Lancet II:1340Google Scholar
  6. 6.
    Laub MC, Paetzke-Brunner I, Jaeger G (1986) Serum carnitine during valproic acid therapy. Epilepsia 27:559–562PubMedGoogle Scholar
  7. 7.
    Mori T, Tsochiyama A, Nagai K, Nagao M, Oyanagi K, Tsugawa S (1990) A case of carbamylphosphate synthetase-I deficiency associated with secondary carnitine deficiency-l-carnitine treatment of CSPI deficiency. Eur J Pediatr 149:272–274PubMedGoogle Scholar
  8. 8.
    O'Connor JE, Costell M, Grisolía S (1987) The potentiation of ammonia toxicity by sodium benzoate is prevented byl-carnitine. Biochem Biophys Res Commun 145:817–824PubMedGoogle Scholar
  9. 9.
    Ohtani Y, Ohyanagi K, Yamamoto S, Matsuda I (1988) Secondary carnitine deficiency in hyperammonemic attacks of ornithine transcarbamylase deficiency. J Pediatr 112:409–414PubMedGoogle Scholar
  10. 10.
    Plasse M, Serre JC, Joannard A, Favier A, Grandgeorges D, Frappat P, Bost M (1980) Forme néonatale svére de citrullinémie, difficulté de la mise en évidence de l'héterozygotie. Interêt du dépistage anténatal. Ann Pédiatr 27:491–496Google Scholar
  11. 11.
    Roe CP, Bohan TP (1982)l-carnitine therapy in propionic-acidemia. Lancet I:1141–1142Google Scholar
  12. 12.
    Seccombe DW, Snyder F, Parson HG (1982)l-carnitine for methylmalonicaciduria. Lancet II:1401–1402Google Scholar
  13. 13.
    Tenenbaum D, Petion AM, Desgres J, Nivelon-Chevalier A, Gambert P, Nivelon JL (1987) Traitement de la citrullinémie. A propos d'un cas pris en charge dès la naissance. Interêt des acides alpha-cétoniques. Arch Fr Pediatr 44:855–861PubMedGoogle Scholar
  14. 14.
    Thoene J, Batshaw M, Spector E (1977) Neonatal citrullinemia: treatment with ketoanalogues of essential amino acids. J Pediatr 90:218–224PubMedGoogle Scholar
  15. 15.
    Walser M, Batshaw M, Sherwood G, Robinson B, Brusilow S (1977) Nitrogen metabolism in neonatal citrullinemia. Clin Sci Mol Med 53:173–181PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • P. Sanjurjo
    • 1
  • J. Rodríguez-Soriano
    • 1
  • A. Vallo
    • 1
  • A. Arranz
    • 1
  • V. Rubio
    • 2
  1. 1.Department of PaediatricsHospital Infantil de Cruces and Basque University School of MedicineBilbaoSpain
  2. 2.Instituto de Investigaciones Citológicas de la Caja de Ahorros de ValenciaValenciaSpain

Personalised recommendations